메뉴 건너뛰기




Volumn 33, Issue 4, 2015, Pages 163.e7-163.e13

Natural history of surgically treated high-risk prostate cancer

(18)  Briganti, Alberto a   Karnes, Robert Jeffrey b   Gandaglia, Giorgio a   Spahn, Martin c   Gontero, Paolo d   Tosco, Lorenzo e   Kneitz, Burkhard f   Chun, Felix K H g   Zaffuto, Emanuele a   Sun, Maxine h   Graefen, Markus g   Marchioro, Giansilvio i   Frohneberg, Detlef j   Giona, Simone d   Karakiewicz, Pierre I h   Van Poppel, Hein e   Montorsi, Francesco a   Joniau, Steven e  


Author keywords

Biochemical recurrence; Cancer specific mortality; Prostate cancer; Radical prostatectomy; Time to biochemical recurrence

Indexed keywords

ADULT; AGED; ARTICLE; BIOCHEMICAL RECURRENCE; BIOCHEMICAL RECURRENCE FREE SURVIVAL; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CHARLSON COMORBIDITY INDEX; COMORBIDITY; FOLLOW UP; GLEASON SCORE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; TERTIARY CARE CENTER; BLOOD; EPIDEMIOLOGY; MIDDLE AGED; MORTALITY; PROGNOSIS; PROSTATIC NEOPLASMS; RISK FACTOR; TUMOR RECURRENCE;

EID: 85006324744     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2014.11.018     Document Type: Article
Times cited : (109)

References (30)
  • 2
    • 84857658304 scopus 로고    scopus 로고
    • A critical analysis of the long-term impact of radical prostatectomy on cancer control and function outcomes
    • Boorjian S.A., Eastham J.A., Graefen M., et al. A critical analysis of the long-term impact of radical prostatectomy on cancer control and function outcomes. Eur Urol 2012, 61:664-675.
    • (2012) Eur Urol , vol.61 , pp. 664-675
    • Boorjian, S.A.1    Eastham, J.A.2    Graefen, M.3
  • 3
    • 79851513695 scopus 로고    scopus 로고
    • Predicting 15-year prostate cancer specific mortality after radical prostatectomy
    • Eggener S.E., Scardino P.T., Walsh P.C., et al. Predicting 15-year prostate cancer specific mortality after radical prostatectomy. J Urol 2011, 185:869-875.
    • (2011) J Urol , vol.185 , pp. 869-875
    • Eggener, S.E.1    Scardino, P.T.2    Walsh, P.C.3
  • 4
    • 84869085747 scopus 로고    scopus 로고
    • The impact of anatomical radical retropubic prostatectomy on cancer control: the 30-year anniversary
    • Mullins J.K., Feng Z., Trock B.J., Epstein J.I., Walsh P.C., Loeb S. The impact of anatomical radical retropubic prostatectomy on cancer control: the 30-year anniversary. J Urol 2012, 188:2219-2224.
    • (2012) J Urol , vol.188 , pp. 2219-2224
    • Mullins, J.K.1    Feng, Z.2    Trock, B.J.3    Epstein, J.I.4    Walsh, P.C.5    Loeb, S.6
  • 5
    • 84874512247 scopus 로고    scopus 로고
    • Impact of age and comorbidities on long-term survival of patients with high-risk prostate cancer treated with radical prostatectomy: a multi-institutional competing-risks analysis
    • Briganti A., Spahn M., Joniau S., et al. Impact of age and comorbidities on long-term survival of patients with high-risk prostate cancer treated with radical prostatectomy: a multi-institutional competing-risks analysis. Eur Urol 2013, 63:693-701.
    • (2013) Eur Urol , vol.63 , pp. 693-701
    • Briganti, A.1    Spahn, M.2    Joniau, S.3
  • 6
    • 79960596998 scopus 로고    scopus 로고
    • Long-term overall survival and metastasis-free survival for men with prostate-specific antigen-recurrent prostate cancer after prostatectomy: analysis of the Center for Prostate Disease Research National Database
    • Antonarakis E.S., Chen Y., Elsamanoudi S.I., et al. Long-term overall survival and metastasis-free survival for men with prostate-specific antigen-recurrent prostate cancer after prostatectomy: analysis of the Center for Prostate Disease Research National Database. BJU Int 2011, 108:378-385.
    • (2011) BJU Int , vol.108 , pp. 378-385
    • Antonarakis, E.S.1    Chen, Y.2    Elsamanoudi, S.I.3
  • 7
    • 83555166131 scopus 로고    scopus 로고
    • The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-up
    • Antonarakis E.S., Feng Z., Trock B.J., et al. The natural history of metastatic progression in men with prostate-specific antigen recurrence after radical prostatectomy: long-term follow-up. BJU Int 2012, 109:32-39.
    • (2012) BJU Int , vol.109 , pp. 32-39
    • Antonarakis, E.S.1    Feng, Z.2    Trock, B.J.3
  • 8
    • 22844434877 scopus 로고    scopus 로고
    • Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy
    • Freedland S.J., Humphreys E.B., Mangold L.A., et al. Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy. J Am Med Assoc 2005, 294:433-439.
    • (2005) J Am Med Assoc , vol.294 , pp. 433-439
    • Freedland, S.J.1    Humphreys, E.B.2    Mangold, L.A.3
  • 10
    • 0141919737 scopus 로고    scopus 로고
    • The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy
    • Ward J.F., Blute M.L., Slezak J., Bergstralh E.J., Zincke H. The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy. J Urol 2003, 170:1872-1876.
    • (2003) J Urol , vol.170 , pp. 1872-1876
    • Ward, J.F.1    Blute, M.L.2    Slezak, J.3    Bergstralh, E.J.4    Zincke, H.5
  • 11
    • 78650251130 scopus 로고    scopus 로고
    • A competing-risks analysis of survival after alternative treatment modalities for prostate cancer patients: 1988-2006
    • Abdollah F., Sun M., Thuret R., et al. A competing-risks analysis of survival after alternative treatment modalities for prostate cancer patients: 1988-2006. Eur Urol 2011, 59:88-95.
    • (2011) Eur Urol , vol.59 , pp. 88-95
    • Abdollah, F.1    Sun, M.2    Thuret, R.3
  • 12
    • 84878059899 scopus 로고    scopus 로고
    • Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. population-based cohort of men with prostate cancer
    • Daskivich T.J., Fan K.H., Koyama T., et al. Effect of age, tumor risk, and comorbidity on competing risks for survival in a U.S. population-based cohort of men with prostate cancer. Ann Intern Med 2013, 158:709-717.
    • (2013) Ann Intern Med , vol.158 , pp. 709-717
    • Daskivich, T.J.1    Fan, K.H.2    Koyama, T.3
  • 13
    • 0032538069 scopus 로고    scopus 로고
    • Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer
    • D'Amico A.V., Whittington R., Malkowicz S.B., et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. J Am Med Assoc 1998, 280:969-974.
    • (1998) J Am Med Assoc , vol.280 , pp. 969-974
    • D'Amico, A.V.1    Whittington, R.2    Malkowicz, S.B.3
  • 14
    • 0023092594 scopus 로고
    • A new method of classifying prognostic comorbidity in longitudinal studies: development and validation
    • Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 1987, 40:373-383.
    • (1987) J Chron Dis , vol.40 , pp. 373-383
    • Charlson, M.E.1    Pompei, P.2    Ales, K.L.3    MacKenzie, C.R.4
  • 15
    • 0000120995 scopus 로고
    • A class of K-sample tests for comparing the cumulative incidence of a competing risk
    • Gray R. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988, 16:1140-1154.
    • (1988) Ann Stat , vol.16 , pp. 1140-1154
    • Gray, R.1
  • 16
    • 1542532754 scopus 로고    scopus 로고
    • A proportional hazards model for the subdistribution of a competing risk
    • Jason P.F., Gray R.J. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999, 94:496-509.
    • (1999) J Am Stat Assoc , vol.94 , pp. 496-509
    • Jason, P.F.1    Gray, R.J.2
  • 17
    • 0028224335 scopus 로고
    • Hazard rate estimation under random censoring with varying kernels and bandwidths
    • Muller H.-G., Wang J.-L. Hazard rate estimation under random censoring with varying kernels and bandwidths. Biometrics 1994, 50:61-76.
    • (1994) Biometrics , vol.50 , pp. 61-76
    • Muller, H.-G.1    Wang, J.-L.2
  • 18
    • 25144458366 scopus 로고    scopus 로고
    • Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function ("trifecta")
    • Bianco F.J., Scardino P.T., Eastham J.A. Radical prostatectomy: long-term cancer control and recovery of sexual and urinary function ("trifecta"). Urology 2005, 66(Suppl. 5):83-94.
    • (2005) Urology , vol.66 , pp. 83-94
    • Bianco, F.J.1    Scardino, P.T.2    Eastham, J.A.3
  • 19
    • 84897091488 scopus 로고    scopus 로고
    • Interval to biochemical recurrence following radical prostatectomy does not affect survival in men with low-risk prostate cancer
    • Bolton D.M., Ta A., Bagnato M., et al. Interval to biochemical recurrence following radical prostatectomy does not affect survival in men with low-risk prostate cancer. World J Urol 2014, 32:431-435.
    • (2014) World J Urol , vol.32 , pp. 431-435
    • Bolton, D.M.1    Ta, A.2    Bagnato, M.3
  • 20
    • 70349313376 scopus 로고    scopus 로고
    • Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era
    • Stephenson A.J., Kattan M.W., Eastham J.A., et al. Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era. J Clin Oncol 2009, 27:4300-4305.
    • (2009) J Clin Oncol , vol.27 , pp. 4300-4305
    • Stephenson, A.J.1    Kattan, M.W.2    Eastham, J.A.3
  • 21
    • 69249208647 scopus 로고    scopus 로고
    • Delayed prostate-specific antigen recurrence after radical prostatectomy: how to identify and what are their clinical outcomes?
    • Caire A.A., Sun L., Ode O., et al. Delayed prostate-specific antigen recurrence after radical prostatectomy: how to identify and what are their clinical outcomes?. Urology 2009, 74:643-647.
    • (2009) Urology , vol.74 , pp. 643-647
    • Caire, A.A.1    Sun, L.2    Ode, O.3
  • 22
    • 33748110792 scopus 로고    scopus 로고
    • Time to prostate specific antigen recurrence after radical prostatectomy and risk of prostate cancer specific mortality
    • Freedland S.J., Humphreys E.B., Mangold L.A., Eisenberger M., Partin A.W. Time to prostate specific antigen recurrence after radical prostatectomy and risk of prostate cancer specific mortality. J Urol 2006, 176(4 Pt 1):1404-1408.
    • (2006) J Urol , vol.176 , Issue.4 , pp. 1404-1408
    • Freedland, S.J.1    Humphreys, E.B.2    Mangold, L.A.3    Eisenberger, M.4    Partin, A.W.5
  • 23
    • 27244451002 scopus 로고    scopus 로고
    • Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy
    • Zhou P., Chen M.H., McLeod D., Carroll P.R., Moul J.W., D'Amico A.V. Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapy. J Clin Oncol 2005, 23:6992-6998.
    • (2005) J Clin Oncol , vol.23 , pp. 6992-6998
    • Zhou, P.1    Chen, M.H.2    McLeod, D.3    Carroll, P.R.4    Moul, J.W.5    D'Amico, A.V.6
  • 24
    • 79955608101 scopus 로고    scopus 로고
    • Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence
    • Boorjian S.A., Thompson R.H., Tollefson M.K., et al. Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence. Eur Urol 2011, 59:893-899.
    • (2011) Eur Urol , vol.59 , pp. 893-899
    • Boorjian, S.A.1    Thompson, R.H.2    Tollefson, M.K.3
  • 25
    • 79960183335 scopus 로고    scopus 로고
    • Can we stop prostate specific antigen testing 10 years after radical prostatectomy?
    • Loeb S., Feng Z., Ross A., Trock B.J., Humphreys E.B., Walsh P.C. Can we stop prostate specific antigen testing 10 years after radical prostatectomy?. J Urol 2011, 186:500-505.
    • (2011) J Urol , vol.186 , pp. 500-505
    • Loeb, S.1    Feng, Z.2    Ross, A.3    Trock, B.J.4    Humphreys, E.B.5    Walsh, P.C.6
  • 26
    • 77956635392 scopus 로고    scopus 로고
    • Lifelong yearly prostate specific antigen surveillance is not necessary for low risk prostate cancer treated with radical prostatectomy
    • Tollefson M.K., Blute M.L., Rangel L.J., Karnes R.J., Frank I. Lifelong yearly prostate specific antigen surveillance is not necessary for low risk prostate cancer treated with radical prostatectomy. J Urol 2010, 184:925-929.
    • (2010) J Urol , vol.184 , pp. 925-929
    • Tollefson, M.K.1    Blute, M.L.2    Rangel, L.J.3    Karnes, R.J.4    Frank, I.5
  • 27
    • 84883772686 scopus 로고    scopus 로고
    • Survival following biochemical recurrence after radical prostatectomy and adjuvant radiotherapy in patients with prostate cancer: the impact of competing causes of mortality and patient stratification
    • Abdollah F., Boorjian S., Cozzarini C., et al. Survival following biochemical recurrence after radical prostatectomy and adjuvant radiotherapy in patients with prostate cancer: the impact of competing causes of mortality and patient stratification. Eur Urol 2013, 64:557-564.
    • (2013) Eur Urol , vol.64 , pp. 557-564
    • Abdollah, F.1    Boorjian, S.2    Cozzarini, C.3
  • 28
    • 0033935812 scopus 로고    scopus 로고
    • Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years
    • Amling C.L., Blute M.L., Bergstralh E.J., Seay T.M., Slezak J., Zincke H. Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years. J Urol 2000, 164:101-105.
    • (2000) J Urol , vol.164 , pp. 101-105
    • Amling, C.L.1    Blute, M.L.2    Bergstralh, E.J.3    Seay, T.M.4    Slezak, J.5    Zincke, H.6
  • 29
    • 84864475599 scopus 로고    scopus 로고
    • Early salvage radiation therapy does not compromise cancer control in patients with pT3N0 prostate cancer after radical prostatectomy: results of a match-controlled multi-institutional analysis
    • Briganti A., Wiegel T., Joniau S., et al. Early salvage radiation therapy does not compromise cancer control in patients with pT3N0 prostate cancer after radical prostatectomy: results of a match-controlled multi-institutional analysis. Eur Urol 2012, 62:472-487.
    • (2012) Eur Urol , vol.62 , pp. 472-487
    • Briganti, A.1    Wiegel, T.2    Joniau, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.